Biocomplexity: A New Science For Survival?

Excerpts from Rita Colwell's interview with The Scientist.This interview was not published in the print edition. Q. Is biocomplexity your own idea? A. The biocomplexity initiative was begun at NSF after I arrived, building on programs already instituted, such as Life in Extreme Environments. The fundamental and underlying principle is that we must move from strictly reductionist research to research that synthesizes information and work toward a holistic approach to understanding and wisely m

Written byArielle Emmett
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Excerpts from Rita Colwell's interview with The Scientist.
This interview was not published in the print edition.

Q. Is biocomplexity your own idea?

A. The biocomplexity initiative was begun at NSF after I arrived, building on programs already instituted, such as Life in Extreme Environments. The fundamental and underlying principle is that we must move from strictly reductionist research to research that synthesizes information and work toward a holistic approach to understanding and wisely managing the environment. We now have the computing capacity to analyze large databases. Thus, we can develop an integrative approach to study of the environment. Some of us remember attempts to build computer models 10 or 25 years ago. We simply weren't advanced sufficiently in either computer information technology or understanding the fundamental elements and constructs that comprise environmental systems. Now we're in a position to be able to study the complexity of ecosystems, especially since mathematicians ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies